Cancer Management in Small Animal Practice - Elsevier eBook on VitalSource, 1st Edition

by Carolyn J. Henry, DVM, MS, DACVIM (Oncology) and Mary Lynn Higginbotham, DVM, MS, DACVIM (Oncology)

Elsevier eBook on VitalSource

ISBN: 9781455757428

Publication Date: 12-03-2009

Page Count: 432

Imprint: Saunders

List Price: $84.99

Was $84.99

Now $74.79

Or $0.00 with a valid access code

Cancer Management in Small Animal Practice provides you with all the tools needed to diagnose, stage, and manage the many different disease entities known as "cancer." This manual is designed to provide you with easy-to-access, clinically relevant details for complete care of the small animal cancer patient, while considering the needs, concerns, and capabilities of the client. It provides quick reference sections for information not included in current oncology texts, including drug interactions and resources for participation in clinical trials. All information is well referenced and the reference section on the accompanying website includes links to the original and related articles.

Key Features
- The latest information including diagnostic procedures, treatment modalities, and outcome predictions to help clients make the best decisions for their pets.
- Expert contributors, renowned for clinical, as well as academic and research expertise, offer a wide breadth and depth of expertise.
- Full-color format provides accurate visual depictions of specific diseases and procedures to enhance your diagnostic capabilities.
- Key Points highlight critical information, enabling quick, easy access.
- Systems approach to diagnosis and management offers logical, systematic, head-to-tail procedure for accurate diagnosis, treatment, and prognosis.
- Extensive discussions of supportive care limit adverse events and increase patient survival and puts emergency information at the practitioner’s fingertips.
- Suggested readings highlight the latest information for further investigation and research.
- Comprehensive drug safety guidelines thoroughly discuss all information required to safely handle and administer cancer drugs.
- Helpful drug formularies offer available formulations, recommended dosages, toxicities, and relative costs.
- Chapter on how to access clinical trials provides helpful information and hope for patients and their caregivers.
Contents

Part 1 Cancer Principles and Concepts

1. Pathophysiology and Tumor Cell Growth

2. Genetic Basis of Cancer

3. Veterinary Cancer Etiology

A. Environmental, Chemical, and Physical Carcinogens

B. Viral Carcinogenesis

C. Hormonal Impact on Carcinogenesis

Part 2 Evidence-Based Approaches to Cancer in Companion Animals

4. Cancer Epidemiology and Statistics

5. Clinical Trial Design and Access to Clinical Research Studies

Part 3 Cancer Diagnosis and Staging

6. Methods of Tumor Diagnosis: Fine-Needle Aspiration and Biopsy Techniques

7. The Cytology of Neoplasia

8. Histopathology, Immunohistochemistry, and Tumor Grading

9. Imaging Methods in Cancer Diagnosis

A. Radiography

B. Ultrasound

C. Endoscopy

10. Advanced Imaging Modalities

A. Positron Emission Tomography (PET)

B. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)

C. Nuclear Scintigraphy

11. Paraneoplastic Syndromes

Part 4 The Management of Cancer

12. Chemotherapy

A. Basic Chemotherapy Principles

B. Chemotherapy Drug Interactions

C. Safe Handling of Chemotherapy Drugs

D. Chemotherapy Preparation

E. Chemotherapy Administration

F. Formulary and Sources of Chemotherapeutic Agents

13. Managing Oncologic Emergencies

A. Tumor- and Treatment-related Complications

B. Treatment of Chemotherapy Extravasations

C. Transfusion Considerations

14. Surgical Interventions in Cancer

15. Radiation Therapy

A. External Beam Radiation Therapy (Teletherapy) and Brachytherapy

B. Radioisotopes in Cancer Therapy

C. Management of Radiation Toxicity and Complications

16. Immunotherapy

17. Photodynamic Therapy

18. Supportive Care of the Cancer Patient

A. Prevention and Management of Nausea and Vomiting

B. Nutritional Management of the Cancer Patient

C. Assessment and Management of Pain in the Cancer Patient

D. Palliative Care for the Cancer Patient

Part 5 Specific Malignancies ― A Head-to-Tail Approach

19. Nervous System Neoplasia

20. Tumors of the Head and Neck

A: Oral Tumors

B: Nasal Tumors

C: Ocular and Periocular Tumors

D: Aural Tumors

E: Skull Tumors

F: Esophageal Tumors

G: Laryngeal and Tracheal Tumors

21. Tumors of the Thoracic Cavity

A: Primary Respiratory Tumors

B: Mediastinal Tumors

C: Metastatic Respiratory Tumors

D: Rib and Pleural Tumors

E: Cardiac and Heart-based Tumors

22. Tumors of the Abdominal Cavity

A: Stomach Tumors

B: Intestinal Tumors

C: Liver, Gall Bladder, and Non-endocrine Pancreatic Tumors

D: Splenic Tumors

E: Female Reproductive Tumors

F: Mammary Tumors

G: Male Reproductive Tumors

H: Renal Tumors

I: Bladder and Urethral Tumors

J: Prostate Tumors

23. Tumors of the Skin, Subcutis, and Other Soft Tissues

A: Skin Tumors

B: Nail Bed Tumors

C: Foot Pad Tumors

D: Mast Cell Tumors

E: Soft-tissue Sarcomas

F: Histiocytic Diseases

G: Perianal and Anal Sac Tumors

24. Tumors of the Musculoskeletal System

25. Tumors of the Hematopoietic System

A: Lymphoma

B: Leukemia

C: Multiple Myeloma

26. Tumors of the Endocrine System

A: Adrenal and Pituitary Tumors

B: Thyroid Tumors

C: Parathyroid Tumors

D: Pancreatic Tumors
Authors

Carolyn J. Henry, DVM, MS, DACVIM (Oncology), Professor of Oncology, Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, and Division of Hematology/Oncology, School of Medicine; Director, Tom and Betty Scott Endowed Program in Veterinary Oncology, University of Missouri, Columbia, MO, USA and Mary Lynn Higginbotham, DVM, MS, DACVIM (Oncology), Assistant Professor, Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - All content can be read as read aloud speech or dynamic braille
- Conformance
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 07-04-2026
- Navigation
  - Table of contents to all chapters of the text via links
  - Page list to go to pages from the print source version
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - Elsevier is committed to making our eBooks accessible and complying with applicable laws. Given our vast library of titles, there are some cases where making an eBook fully accessible presents unique challenges, and including full features could transform its nature to no longer serve its primary purpose or result in a disproportionate burden for the publisher. As a result this eBook may have limited accessibility. See more at https://www.elsevier.com/en-gb/about/accessibility.
  - Please refer to our disproportionate burden or fundamental modification statements.
- Additional Accessibility Information
  - Page breaks included from the original print source
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.